AAM
Advisors Asset Management Portfolio holdings
AUM
$5.89B
1-Year Est. Return
18.5%
1 Year Est. Return
+18.5%
AUM
$5.89B
AUM Growth
+$306M
(+5.5%)
Holding
1,527
Top Buys
| 1 | +$9.49M | |
| 2 | +$6.4M | |
| 3 | +$5.03M | |
| 4 |
DPG
Duff & Phelps Utility and Infrastructure Fund
DPG
|
+$4.41M |
| 5 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$3.76M |
Top Sells
| 1 | +$11M | |
| 2 | +$9.58M | |
| 3 | +$9.26M | |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$8.31M |
| 5 |
EIPI
FT Energy Income Partners Enhanced Income ETF
EIPI
|
+$7.28M |
Sector Composition
| 1 | Technology | 19.13% |
| 2 | Industrials | 12.67% |
| 3 | Financials | 10.21% |
| 4 | Communication Services | 8.71% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Kymera Therapeutics
KYMR
$6.37B
| $280K | ﹤0.01% |
4,943
-19
|
|
||
1077
Ross Stores
ROST
$59.5B
| $279K | ﹤0.01% |
1,828
-110
|
|
||
1078
FS Bancorp
FSBW
$322M
| $277K | ﹤0.01% |
6,948
-1,868
|
|
||
1079
Crinetics Pharmaceuticals
CRNX
$4.76B
| $277K | ﹤0.01% |
6,652
-24
|
|
||
1080
Burlington
BURL
$16.8B
| $276K | ﹤0.01% |
1,083
+107
|
|
||
1081
Rentokil
RTO
$14.4B
| $270K | ﹤0.01% |
10,675
+3,065
|
|
||
1082
Western Digital
WDC
$60.2B
| $268K | ﹤0.01% |
2,231
+253
|
|
||
1083
Preferred Bank
PFBC
$1.23B
| $264K | ﹤0.01% |
2,926
-1,300
|
|
||
1084
Celanese
CE
$4.81B
| $260K | ﹤0.01% |
6,182
-103
|
|
||
1085
Texas Roadhouse
TXRH
$11.2B
| $258K | ﹤0.01% |
1,553
+193
|
|
||
1086
Lazard
LAZ
$4.77B
| $254K | ﹤0.01% |
4,816
-229
|
|
||
1087
Cameco
CCJ
$39.3B
| $252K | ﹤0.01% |
3,008
+1,269
|
|
||
1088
Regal Rexnord
RRX
$9.92B
| $251K | ﹤0.01% |
1,748
+120
|
|
||
1089
Genpact
G
$8.15B
| $248K | ﹤0.01% |
5,917
-2,970
|
|
||
1090
VF Corp
VFC
$7.71B
| $246K | ﹤0.01% |
17,045
-14,674
|
|
||
1091
La-Z-Boy
LZB
$1.63B
| $246K | ﹤0.01% |
7,163
-1,512
|
|
||
1092
Ferrari
RACE
$65.1B
| $239K | ﹤0.01% |
492
+47
|
|
||
1093
Interparfums
IPAR
$2.69B
| $238K | ﹤0.01% |
2,424
-416
|
|
||
1094
Nordson
NDSN
$13.1B
| $238K | ﹤0.01% |
1,047
-380
|
|
||
1095
Sarepta Therapeutics
SRPT
$2.24B
| $234K | ﹤0.01% |
12,166
-378
|
|
||
1096
Baidu
BIDU
$43.2B
| $231K | ﹤0.01% |
1,753
-9
|
|
||
1097
Summit Therapeutics
SMMT
$13B
| $230K | ﹤0.01% |
11,130
-43
|
|
||
1098
HealthEquity
HQY
$8.4B
| $229K | ﹤0.01% |
2,413
-24
|
|
||
1099
Vericel Corp
VCEL
$1.85B
| $228K | ﹤0.01% |
7,238
-1,403
|
|
||
1100
Koppers
KOP
$575M
| $226K | ﹤0.01% |
8,089
-176
|
|